-

Promega Earns a 2022 Top Workplaces USA Award

Biotech company recognized for culture supporting work-life balance

MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation was recognized today as a top place to work in the US with a 2022 Top Workplaces USA award. Companies earn a place on the Top Workplaces USA list based solely on employee engagement surveys compiled by research firm Energage.

More than 1,100 companies across four size categories were recognized as national winners. Promega ranked in the top 50 among companies with 1,000-2,499 employees. Feedback from Promega employees showed that the biotechnology manufacturer’s strongest culture driver is its support of work-life balance.

“We faced a lot of extremes together over the past two years in our global role supporting COVID-19 testing and research,” says Promega Director of HR Organizational Development Darbie Miller. “Our employees rose to that challenge and it’s meaningful to all of us that they continue to experience a culture that prioritizes flexibility to balance work and personal life. We are honored to receive this recognition and also to understand from all the survey feedback how to continue to evolve the employee experience at Promega.”

Promega, a global manufacturer of reagents, assays and benchtop instruments for the life science industry, employs more than 1800 people worldwide with more than 1200 of those employees at its Madison, WI facilities. The company experienced an approximate 10-fold increase in demand for products at the onset of the COVID-19 pandemic and employed several measures to scale up operations.

Winners of the Top Workplaces USA list are calculated by comparing the Energage employee engagement survey’s research-based statements, including 15 Culture Drivers, to predict high performance against industry benchmarks. Promega earned recognition for “Work-Life Balance” because the company’s results in this area were in the top 25% of organizations surveyed in the past 12 months.

The Promega employee base contributes a wide range of skills and disciplines in research & development, logistics, manufacturing, engineering, information technology, sales, marketing, customer service, technical service, training, human resources, and communications. To learn more about Promega and current job openings, visit: https://www.promega.com/aboutus/careers/

About Promega Corporation

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s portfolio of over 4,000 products support a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. For over 40 years these tools and technologies have grown in their application and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information, visit www.promega.com

Contacts

Penny Patterson
VP, Corporate Affairs
Promega Corporation
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com

Promega Corporation


Release Summary
Promega is named to the 2022 Top Workplaces USA list recognizing companies across the country that have built exceptional workplace cultures.
Release Versions

Contacts

Penny Patterson
VP, Corporate Affairs
Promega Corporation
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com

Social Media Profiles
More News From Promega Corporation

China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA®

MADISON, Wis.--(BUSINESS WIRE)--The NMPA has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China....

Study Establishes Molecular Link Between Tumor Metabolism and Drug Engagement in Cancer Cells

MADISON, Wis.--(BUSINESS WIRE)--A new study published in Nature Communications illuminates uncompetitive inhibitor binding in live cells, enabling future precision oncology research....

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma

MADISON, Wis.--(BUSINESS WIRE)--The Promega OncoMate® MSI Dx Analysis System has received FDA approval as a companion diagnostic for KEYTRUDA® plus LENVIMA® in endometrial carcinoma....
Back to Newsroom